Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function.
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2020
|
Online Access: | http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0034-83762020000300159 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0034-837620200003001592021-04-30Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot StudyOlivares-Gazca,Juan C.Priesca-Marín,Jose M.Ojeda-Laguna,MartínGarces-Eisele,JavierSoto-Olvera,SilviaPalacios-Alonso,AbrahamIzquierdo-Vega,JudithChacon-Cano,RómuloArizpe-Bravo,DanielLópez-Trujillo,Miguel A.Cantero-Fortiz,YahvethFernandez-Lara,DanitzaRuiz-Delgado,Guillermo J.Ruiz-Argüelles,Guillermo J. Convalescent plasma Coronavirus disease-19 Severe coronavirus disease-19 ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function.info:eu-repo/semantics/openAccessInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránRevista de investigación clínica v.72 n.3 20202020-06-01info:eu-repo/semantics/reporttext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159en10.24875/ric.20000237 |
institution |
SCIELO |
collection |
OJS |
country |
México |
countrycode |
MX |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-mx |
tag |
revista |
region |
America del Norte |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Olivares-Gazca,Juan C. Priesca-Marín,Jose M. Ojeda-Laguna,Martín Garces-Eisele,Javier Soto-Olvera,Silvia Palacios-Alonso,Abraham Izquierdo-Vega,Judith Chacon-Cano,Rómulo Arizpe-Bravo,Daniel López-Trujillo,Miguel A. Cantero-Fortiz,Yahveth Fernandez-Lara,Danitza Ruiz-Delgado,Guillermo J. Ruiz-Argüelles,Guillermo J. |
spellingShingle |
Olivares-Gazca,Juan C. Priesca-Marín,Jose M. Ojeda-Laguna,Martín Garces-Eisele,Javier Soto-Olvera,Silvia Palacios-Alonso,Abraham Izquierdo-Vega,Judith Chacon-Cano,Rómulo Arizpe-Bravo,Daniel López-Trujillo,Miguel A. Cantero-Fortiz,Yahveth Fernandez-Lara,Danitza Ruiz-Delgado,Guillermo J. Ruiz-Argüelles,Guillermo J. Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
author_facet |
Olivares-Gazca,Juan C. Priesca-Marín,Jose M. Ojeda-Laguna,Martín Garces-Eisele,Javier Soto-Olvera,Silvia Palacios-Alonso,Abraham Izquierdo-Vega,Judith Chacon-Cano,Rómulo Arizpe-Bravo,Daniel López-Trujillo,Miguel A. Cantero-Fortiz,Yahveth Fernandez-Lara,Danitza Ruiz-Delgado,Guillermo J. Ruiz-Argüelles,Guillermo J. |
author_sort |
Olivares-Gazca,Juan C. |
title |
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
title_short |
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
title_full |
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
title_fullStr |
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
title_full_unstemmed |
Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study |
title_sort |
infusion of convalescent plasma is associated with clinical improvement in critically ill patients with covid-19: a pilot study |
description |
ABSTRACT Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study the safety and outcomes of the administration of CoPla to individuals with severe COVID-19 in an academic medical center. Methods: Ten patients were prospectively treated with plasma from COVID-19 convalescent donors. Results: Over 8 days, the sequential organ failure assessment score dropped significantly in all patients, from 3 to 1.5 (p = 0.014); the Kirby index (PaO2/FiO2) score increased from 124 to 255, (p < 0.0001), body temperature decreased significantly from 38.1 to 36.9°C (p = 0.0058), and ferritin levels also dropped significantly from 1736.6 to 1061.8 ng/ml (p = 0.0001). Chest X-rays improved in 7/10 cases and in 6/10, computerized tomography scans also revealed improvement of the lung injury. Decreases in C-reactive protein and D-dimer levels were also observed. Three of five patients on mechanical ventilation support could be extubated, nine were transferred to conventional hospital floors, and six were sent home; two patients died. The administration of CoPla had no side effects and the 24-day overall survival was 77%. Conclusions: Although other treatments were also administered to the patients and as a result data are difficult to interpret, it seems that the addition of CoPla improved pulmonary function. |
publisher |
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán |
publishDate |
2020 |
url |
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762020000300159 |
work_keys_str_mv |
AT olivaresgazcajuanc infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT priescamarinjosem infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT ojedalagunamartin infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT garceseiselejavier infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT sotoolverasilvia infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT palaciosalonsoabraham infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT izquierdovegajudith infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT chaconcanoromulo infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT arizpebravodaniel infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT lopeztrujillomiguela infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT canterofortizyahveth infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT fernandezlaradanitza infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT ruizdelgadoguillermoj infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy AT ruizarguellesguillermoj infusionofconvalescentplasmaisassociatedwithclinicalimprovementincriticallyillpatientswithcovid19apilotstudy |
_version_ |
1756219783578124288 |